{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:13:51Z","timestamp":1793391231527,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"ISCIII","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jtha.2026.08.016","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T07:04:54Z","timestamp":1787814294000},"page":"3874-3883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The tissue factor-TFPI pathway as a therapeutic target in bleeding disorders of unknown cause"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7967-6358","authenticated-orcid":false,"given":"Elena","family":"Monz\u00f3n Manzano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0259-8056","authenticated-orcid":false,"given":"Paula","family":"Acu\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Mart\u00edn Salces","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Isabel","family":"Rivas Pollmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Garc\u00eda P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"Mart\u00edn de Bustamante Gonz\u00e1lez-Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3937-3499","authenticated-orcid":false,"given":"V\u00edctor","family":"Jim\u00e9nez Yuste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4601-7150","authenticated-orcid":false,"given":"Nora","family":"Butta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3296-4288","authenticated-orcid":false,"given":"Mar\u00eda Teresa","family":"\u00c1lvarez Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.08.016_bib1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/hae.13422","article-title":"High proportion of patients with bleeding of unknown cause in persons with a mild-to-moderate bleeding tendency: results from the Vienna Bleeding Biobank (VIBB)","volume":"24","author":"Gebhart","year":"2018","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.08.016_bib2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/jth.14363","article-title":"Diagnostic challenges of inherited mild bleeding disorders: a bait for poorly explored clinical and basic research","volume":"17","author":"Mezzano","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.08.016_bib3","article-title":"Bleeding disorder of unknown cause: an illustrated review on current practice, knowledge gaps, and future perspectives","volume":"8","author":"Monard","year":"2024","journal-title":"Res Prac Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.08.016_bib4","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.jtha.2024.03.005","article-title":"Isth Ssc Von Willebrand Factor PP, Women\u2019s Health Issues in T, Haemostasis. Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTH","volume":"22","author":"Baker","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.08.016_bib5","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/hae.70065","article-title":"Current practice regarding bleeding disorders of unknown cause in the Netherlands: a national survey","volume":"31","author":"Mussert","year":"2025","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.08.016_bib6","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1016\/j.jtha.2024.05.027","article-title":"Examining variability in the diagnosis and management of people with bleeding disorders of unknown cause: communication from the ISTH SSC Subcommittee on von Willebrand Factor","volume":"22","author":"Kelly","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.08.016_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/hae.12811","article-title":"Unclassified bleeding disorders: outcome of haemostatic challenges following tranexamic acid and\/or desmopressin","volume":"22","author":"Obaji","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.08.016_bib8","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1055\/s-0041-1726344","article-title":"Outcome of surgical interventions and deliveries in patients with bleeding of unknown cause: an observational study","volume":"121","author":"Veen","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.08.016_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2025.109404","article-title":"tPA-ROTEM identifies hyperfibrinolytic profile in a significant proportion of patients with bleeding disorder of unknown cause (BDUC)","volume":"253","author":"Monard","year":"2025","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.08.016_bib10","doi-asserted-by":"crossref","first-page":"17838","DOI":"10.1073\/pnas.1310444110","article-title":"Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation","volume":"110","author":"Wood","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2026.08.016_bib11","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1182\/blood-2013-11-512764","article-title":"Biology of tissue factor pathway inhibitor","volume":"123","author":"Wood","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.08.016_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.670526","article-title":"Progress in the development of anti-tissue factor pathway inhibitors for haemophilia management","volume":"8","author":"Mahlangu","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.jtha.2026.08.016_bib13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/a-2263-5706","article-title":"Bleeding disorder of unknown cause: a diagnosis of exclusion","volume":"44","author":"Mehic","year":"2024","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.jtha.2026.08.016_bib14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.08.016_bib15","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.jtha.2025.01.011","article-title":"Platelet function analyzer (PFA-100) in patients with mild-to-moderate bleeding disorders and bleeding disorder of unknown cause","volume":"23","author":"Mehic","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.08.016_bib16","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/bjh.18003","article-title":"Multiparameter platelet function analysis of bleeding patients with a prolonged platelet function analyser closure time","volume":"196","author":"Heubel-Moenen","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.08.016_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ab.2011.12.036","article-title":"Measuring the mechanical properties of blood clots formed via the tissue factor pathway of coagulation","volume":"422","author":"Foley","year":"2012","journal-title":"Anal Biochem"},{"key":"10.1016\/j.jtha.2026.08.016_bib18","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1055\/a-2330-9112","article-title":"Utility of global hemostatic assays in patients with bleeding disorders of unknown cause","volume":"44","author":"Mehic","year":"2024","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.jtha.2026.08.016_bib19","article-title":"Impaired thrombin generation as a reproducible feature of bleeding disorder of unknown cause","volume":"10","author":"Dreier","year":"2026","journal-title":"Res Prac Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.08.016_bib20","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1182\/blood.2025029571","article-title":"Human missense variants in F3 impair the initiation of blood coagulation","volume":"147","author":"Ansari","year":"2026","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.08.016_bib21","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1172\/JCI133780","article-title":"A coagulation defect arising from heterozygous premature termination of tissue factor","volume":"130","author":"Schulman","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2026.08.016_bib22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1182\/bloodadvances.2020003464","article-title":"Elevated levels of tissue factor pathway inhibitor in patients with mild to moderate bleeding tendency","volume":"5","author":"Mehic","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.08.016_bib23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/ijlh.12508","article-title":"Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders","volume":"38","author":"Dahlback","year":"2016","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2026.08.016_bib24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jtha.2022.10.005","article-title":"Tissue factor pathway inhibitor is a potential modifier of bleeding risk in factor XI deficiency","volume":"21","author":"Reitsma","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.08.016_bib25","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJMoa2216455","article-title":"Phase 3 Trial of Concizumab in Hemophilia with Inhibitors","volume":"389","author":"Matsushita","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.08.016_bib26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bcmd.2013.09.001","article-title":"An acquired, calcium-dependent, factor X inhibitor","volume":"52","author":"Broze","year":"2014","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jtha.2026.08.016_bib27","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/jth.15697","article-title":"Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy","volume":"20","author":"Mast","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.08.016_bib28","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/a-2561-6786","article-title":"Accelerated Fibrinolysis: A tendency to bleed?","volume":"45","author":"Mehic","year":"2025","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.jtha.2026.08.016_bib29","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1182\/blood-2014-10-604553","article-title":"Characterization of an autosomal dominant bleeding disorder caused by a thrombomodulin mutation","volume":"125","author":"Dargaud","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.08.016_bib30","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1182\/blood-2014-02-557538","article-title":"A hereditary bleeding disorder resulting from a premature stop codon in thrombomodulin (p.Cys537Stop)","volume":"124","author":"Langdown","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.08.016_bib31","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1111\/jth.14990","article-title":"A new pedigree with thrombomodulin-associated coagulopathy in which delayed fibrinolysis is partially attenuated by co-inherited TAFI deficiency","volume":"18","author":"Westbury","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.08.016_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/hae.70278","article-title":"Rare bleeding disorders and bleeding disorder of unknown cause: current understanding and recent developments","author":"Casini","year":"2026","journal-title":"Haemophilia"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626005404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626005404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:03:32Z","timestamp":1793351012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626005404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1538783626005404"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.08.016","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The tissue factor-TFPI pathway as a therapeutic target in bleeding disorders of unknown cause","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}